EDMONTON, Alberta, Nov. 9 /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that interest and sales in its VScan Dengue Fever test kit continues to grow. Major outbreaks of Dengue Fever are occurring throughout Africa, Middle East, Pakistan, and Southeast Asia. There are also outbreaks in the Caribbean. Medical Services currently sells VScan Dengue Fever test kits into 12 different countries. Our distributors have arranged for testing to be completed in an additional 10 countries. The Company has begun negotiations with several established medical supply companies to become distributors in Pakistan. The Company projects that it will sell in excess of 1.0 million VScan Dengue Fever test kits over the next year generating $2.5 million US in revenue. Dengue Fever is spread by mosquitoes. Control of Dengue Fever is based on early detection. Some forms of Dengue Fever kill within days of contracting the disease. Standard laboratories take up to 5 weeks to complete testing for Dengue Fever. Early detection of Dengue Fever allows for containment of the virus which stops the spread. The VScan Dengue Fever test kit gives results in under 20 minutes with an accuracy greater than 99%. About VScan The VScan rapid test kit is a single use, disposable, accurate, cost effective, east to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada. Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ . NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and filings with regulatory bodies. DATASOURCE: Medical Services International Inc. CONTACT: Robert Talbot of Medical Services International Inc., +1-780-430-6363 Web site: http://www.medicalservicesintl.com/ http://www.minerva-biotech.com/

Copyright